CSIMarket
 


Regenerx Biopharmaceuticals inc   (RGRX)
Other Ticker:  
 

Regenerx Biopharmaceuticals Inc 's Working Capital Ratio

RGRX's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


In the wake of the increase in Current Liabilities in the first quarter 2023, Working Capital Ratio fell to 0.07 below Regenerx Biopharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry 564 other companies have achieved higher Working Capital Ratio than Regenerx Biopharmaceuticals Inc in first quarter 2023. While Working Capital Ratio total ranking in the first quarter 2023 has deteriorated compared to the prior quarter from 4705 to 5165.

Explain Working Capital Ratio
How much in Current Assets RGRX´s has?
What is the value of RGRX´s Current Liabilities?


RGRX Working Capital Ratio (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Current Liabilities Change 346.55 % 28.8 % 14.06 % -31.61 % -6.65 %
Y / Y Current Assets Change -86.87 % -75.48 % -67.76 % -64.71 % 274.15 %
Working Capital Ratio MRQ 0.07 0.55 1.05 1.68 2.33
RGRX's Total Ranking # 5165 # 4705 # 3712 # 3727 # 2092
Seq. Current Liabilities Change 225.01 % 16.27 % 10 % 7.42 % -6.26 %
Seq. Current Assets Change -59.84 % -38.54 % -31.17 % -22.69 % -25.01 %



Working Capital Ratio first quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 565
Healthcare Sector # 1139
Overall Market # 5165


Working Capital Ratio Statistics
High Average Low
6.17 1.54 0.02
(Jun 30 2019)  




Financial Statements
Regenerx Biopharmaceuticals Inc 's Current Liabilities $ 2 Millions Visit RGRX's Balance sheet
Regenerx Biopharmaceuticals Inc 's Current Assets $ 0 Millions Visit RGRX's Balance sheet
Source of RGRX's Sales Visit RGRX's Sales by Geography


Cumulative Regenerx Biopharmaceuticals Inc 's Working Capital Ratio

RGRX's Working Capital Ratio for the trailling 12 Months

RGRX Working Capital Ratio

(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Current Liabilities TTM Growth 346.55 % 28.8 % 14.06 % -31.61 % -6.65 %
Y / Y Current Assets TTM Growth -86.87 % -75.48 % -67.76 % -64.71 % 274.15 %
Working Capital Ratio TTM 0.51 1.32 1.96 2.65 3.08
Total Ranking TTM # 4387 # 4401 # 4317 # 1827 # 1612
Seq. Current Liabilities TTM Growth 225.01 % 16.27 % 10 % 7.42 % -6.26 %
Seq. Current Assets TTM Growth -59.84 % -38.54 % -31.17 % -22.69 % -25.01 %


On the trailing twelve months basis Due to in Current Liabilities in the I Quarter 2023 to $1.80 millions, cumulative Working Capital Ratio decreased to 0.51 below the Regenerx Biopharmaceuticals Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 552 other companies have achieved higher Working Capital Ratio than Regenerx Biopharmaceuticals Inc . While Working Capital Ratio overall ranking has improved so far to 4387, from total ranking during the twelve months ending forth quarter 2022 at 4401.

Explain Working Capital Ratio
How much in Current Assets RGRX´s has?
What is the value of RGRX´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 553
Healthcare Sector # 1134
Within the Market # 4387


trailing twelve months Working Capital Ratio Statistics
High Average Low
3.76 1.7 0.29
(Dec 31 2019)   (Dec 31 2017)




Companies with similar Working Capital Ratio in the quarter ending Mar 31 2023, within Major Pharmaceutical Preparations Industry Working Capital RatioMar 31 2023 MRQ Current AssetsMar 31 2023 MRQ Current Liabilities
Aridis Pharmaceuticals Inc   0.19 $ 6.566  Millions$ 35.431  Millions
Provectus Biopharmaceuticals Inc   0.18 $ 1.596  Millions$ 8.660  Millions
Scopus Biopharma Inc   0.17 $ 1.601  Millions$ 9.313  Millions
Nascent Biotech Inc  0.16 $ 0.255  Millions$ 1.551  Millions
Conduit Pharmaceuticals Inc   0.16 $ 0.310  Millions$ 1.958  Millions
Protokinetix Incorporated  0.15 $ 0.008  Millions$ 0.053  Millions
Innovation1 Biotech Inc   0.15 $ 0.352  Millions$ 2.335  Millions
One World Products Inc   0.14 $ 0.448  Millions$ 3.118  Millions
Emmaus Life Sciences Inc   0.13 $ 7.418  Millions$ 57.855  Millions
Bespoke Extracts Inc   0.12 $ 0.149  Millions$ 1.249  Millions
Cytodyn inc   0.12 $ 14.110  Millions$ 121.334  Millions
Humanigen Inc  0.09 $ 5.026  Millions$ 53.296  Millions
Aeon Biopharma inc   0.09 $ 0.542  Millions$ 5.873  Millions
Agex Therapeutics Inc   0.08 $ 1.747  Millions$ 21.448  Millions
Regenerx Biopharmaceuticals inc   0.07 $ 0.123  Millions$ 1.800  Millions
Rapid Therapeutic Science Laboratories Inc   0.06 $ 0.251  Millions$ 4.463  Millions
Cell Source Inc   0.05 $ 0.218  Millions$ 4.053  Millions
Cnbx Pharmaceuticals Inc   0.05 $ 0.109  Millions$ 2.250  Millions
Sangui Biotech International Inc  0.04 $ 0.039  Millions$ 1.027  Millions
Bioxytran Inc   0.04 $ 0.154  Millions$ 4.243  Millions
Earth Science Tech Inc   0.04 $ 0.046  Millions$ 1.307  Millions
Regen Biopharma Inc  0.03 $ 0.184  Millions$ 5.336  Millions
Propanc Biopharma Inc   0.03 $ 0.097  Millions$ 3.060  Millions
Actavia Life Sciences Inc   0.03 $ 0.052  Millions$ 1.923  Millions
Skinvisible Inc   0.03 $ 0.073  Millions$ 2.726  Millions
Novaccess Global Inc   0.02 $ 0.103  Millions$ 5.830  Millions

Date modified: 2023-05-17T01:10:57+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com